{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:50:35Z","timestamp":1768701035213,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Fluoresc"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10895-021-02862-6","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:03:06Z","timestamp":1641859386000},"page":"603-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Selective Spectrofluorimetric Protocol for Determination of Commonly Used Gram-negative Bactericidal Drug in Combined Pharmaceutical Dosage Forms and Human Plasma"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7241-2130","authenticated-orcid":false,"given":"Tamer Z.","family":"Attia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Abdelmajed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid M. Badr","family":"El-Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"2862_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jgar.2017.09.011","volume":"12","author":"YD Bakthavatchalam","year":"2018","unstructured":"Bakthavatchalam YD, Pragasam AK, Biswas I, Veeraraghavan B (2018) Polymyxin susceptibility testing, interpretative breakpoints, and resistance mechanisms: An update. J Glob Antimicrob Resist 12:124\u2013136","journal-title":"J Glob Antimicrob Resist"},{"key":"2862_CR2","doi-asserted-by":"crossref","unstructured":"Quintanilha JC, da Costa Duarte N, Lloret GR, Visacri MB, Mattos KP, Dragosavac D, Falc\u00e3o AL, Moriel P (2019)\u00a0Colistin and polymyxin B for treatment of nosocomial infections in intensive care unit patients: pharmacoeconomic analysis. Int J Clin Pharm 41:74\u201380","DOI":"10.1007\/s11096-018-0766-x"},{"key":"2862_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ja.2016.146","volume":"70","author":"P Brown","year":"2017","unstructured":"Brown P, Dawson MJ (2017) Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections. J Antibiot (Tokyo) 70:386\u2013394","journal-title":"J Antibiot (Tokyo)"},{"key":"2862_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2147\/IDR.S169939","volume":"11","author":"T Ngamprasertchai","year":"2018","unstructured":"Ngamprasertchai T, Boonyasiri A, Charoenpong L, Nimitvilai S, Lorchirachoonkul N, Wattanamongkonsil L, Thamlikitkul V (2018) Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant gram-negative bacteria in Thailand. Infect Drug Resist 11:1219\u20131224","journal-title":"Infect Drug Resist"},{"key":"2862_CR5","first-page":"1","volume":"7","author":"S Pan","year":"2018","unstructured":"Pan S, Huang X, Wang Y, Li L, Zhao C, Yao Z, Cui W, Zhang G (2018) Efficacy of intravenous plus intrathecal\/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR\/XDR Acinectobacter baumannii: A retrospective cohort study, Antimicrob. Resist. Infect Control 7:1\u20139","journal-title":"Infect Control"},{"key":"2862_CR6","doi-asserted-by":"crossref","unstructured":"Rocha ED, Ferreira MR, dos Santos Neto E, Barbosa EJ, L\u00f6benberg R, Louren\u00e7o FR, Bou-Chacra N (2020)\u00a0Enhanced In vitro antimicrobial activity of polymyxin B\u2013coated nanostructured lipid carrier containing dexamethasone acetate. J Pharm Innov\u00a01\u201311","DOI":"10.1007\/s12247-020-09427-3"},{"key":"2862_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1097\/ICO.0000000000002414","volume":"39","author":"E Laskey","year":"2020","unstructured":"Laskey E, Chen Y, Sohn MB, Gruber E, Chojnacki M, Wozniak RAF (2020) Efficacy of a Novel Ophthalmic Antimicrobial Drug Combination Toward a Large Panel of Staphylococcus aureus Clinical Ocular Isolates From Around the World. Cornea 39:1278\u20131284","journal-title":"Cornea"},{"key":"2862_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-017-0133-4","volume":"7","author":"NA Moore","year":"2017","unstructured":"Moore NA, Czyz CN, Carter TD, Foster JA, Cahill KV (2017) Neomycin, polymyxin B, and dexamethasone allergic reactions following periocular surgery. J Ophthalmic Inflamm Infect 7:1\u20134","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2862_CR9","doi-asserted-by":"crossref","unstructured":"Tang J, Guan H, Dong W, Liu Y, Dong J, Huang L, Zhou J, Lu S (2020)\u00a0Application of compound polymyxin B ointment in the treatment of chronic refractory wounds. Int J Low Extrem Wounds","DOI":"10.1177\/1534734620944512"},{"key":"2862_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0731-7085(00)00438-6","volume":"24","author":"J Krzek","year":"2001","unstructured":"Krzek J, Starek M, Kwiecie\u0144 A, Rzeszutko W (2001) Simultaneous identification and quantitative determination of neomycin sulfate, polymixin B sulfate, zinc bacytracin, and methyl and propyl hydroxybenzoates in ophthalmic ointment by TLC. J Pharm Biomed Anal 24:629\u2013636","journal-title":"J Pharm Biomed Anal"},{"key":"2862_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/jac\/dkn343","volume":"62","author":"G Cao","year":"2008","unstructured":"Cao G, Ali FEA, Chiu F, Zavascki AP, Nation RL, Li J (2008) Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma. J Antimicrob Chemother 62:1009\u20131014","journal-title":"J Antimicrob Chemother"},{"key":"2862_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/FTD.0b013e31825c827a","volume":"34","author":"TA Thomas","year":"2012","unstructured":"Thomas TA, Broun EC, Abildskov KM, Kubin CJ, Horan J, Yin MT, Cremers S (2012) High-performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma. Ther Drug Monit 34:389","journal-title":"Ther Drug Monit"},{"key":"2862_CR13","doi-asserted-by":"crossref","unstructured":"Covelli J, Ruszaj D, Straubinger R, Li J, Rao GG (2017)\u00a0The development and validation of a simple liquid chromatography-tandem mass spectrometry method for polymyxin B1 and B2 quantification in different matrices. J Chromatogr B Anal Technol Biomed Life Sci 1065:112\u2013118","DOI":"10.1016\/j.jchromb.2017.09.031"},{"key":"2862_CR14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4155\/bio-2020-0051","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu X, Yu Z, Wang Y, Wu H, Bian X, Li X, Fan Y, Guo B, Zhang J (2020) Therapeutic drug monitoring of polymyxin B by LC-MS\/MS in plasma and urine. Bioanalysis 12:845\u2013855","journal-title":"Bioanalysis"},{"key":"2862_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/FTD.0000000000000754","volume":"42","author":"P Wang","year":"2020","unstructured":"Wang P, Zhang Q, Qin Z, Xing H, Xu M, Pei H, Yang J, Zhang X (2020) A Simple and Robust Liquid Chromatography With Tandem Mass Spectrometry Analytical Method for Therapeutic Drug Monitoring of Plasma and Cerebrospinal Fluid Polymyxin B1 and B2. Ther Drug Monit 42:716\u2013723","journal-title":"Ther Drug Monit"},{"key":"2862_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jpba.2004.08.011","volume":"36","author":"M Pendela","year":"2004","unstructured":"Pendela M, Adams E, Hoogmartens J (2004) Development of a liquid chromatographic method for ear drops containing neomycin sulfate, polymyxin B sulfate, and dexamethasone sodium phosphate. J Pharm Biomed Anal 36:751\u2013757","journal-title":"J Pharm Biomed Anal"},{"key":"2862_CR17","first-page":"33","volume":"5","author":"A Mannan","year":"2017","unstructured":"Mannan A, Khan AJ, Khan M, Abbas G (2017) Validated Spectrophotometric Method for Determination of Polymaxin-B Sulfate in Pharmaceutical Formulations. RADS J Pharm Pharm Sci 5:33\u201338","journal-title":"RADS J Pharm Pharm Sci"},{"key":"2862_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1081\/AL-100104152","volume":"34","author":"JML Gallego","year":"2001","unstructured":"Gallego JML, Arroyo JP (2001) Simultaneous resolution of dexamethasone and polymyxin B by spectrophotometry derivative and multivariate methods. Anal Lett 34:1265\u20131283","journal-title":"Anal Lett"},{"key":"2862_CR19","doi-asserted-by":"crossref","unstructured":"Gallego JL, Arroyo JP\u00a0(2001) Spectrophotometric resolution of ternary mixtures of Dexamethasone, Polymyxin B, and Trimethoprim in synthetic and pharmaceutical formulations. Anal Chim Acta 437:247\u2013257","DOI":"10.1016\/S0003-2670(01)01008-X"},{"key":"2862_CR20","first-page":"693","volume":"70","author":"P Severino","year":"2015","unstructured":"Severino P, Silveira EF, Vazzana M, Chaud MV, Santana MHA, Souto EB (2015) Validation of a UV spectrophotometric assay for the quantification of polymyxin B in solid lipid nanoparticles. Pharmazie 70:693\u2013697","journal-title":"Pharmazie"},{"key":"2862_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10895-015-1555-8","volume":"25","author":"AM El-Kosasy","year":"2015","unstructured":"El-Kosasy AM, Abdel-Aziz O, Magdy N, El Zahar NM (2015) Screening and optimization of the reaction of polymyxin B sulfate with NBD-Cl for the synchronous spectrofluorimetric determination of polymyxin B sulfate in human plasma. J Fluoresc 25:695\u2013705","journal-title":"J Fluoresc"},{"key":"2862_CR22","doi-asserted-by":"crossref","unstructured":"Baron D, Rozsypal J, Michel A, Secret E, Siaugue JM, Pluh\u00e1\u010dek T, Petr J (2020)\u00a0Study of interactions between carboxylated core-shell magnetic nanoparticles and polymyxin B by capillary electrophoresis with inductively coupled plasma mass spectrometry. J Chromatogr A 1609","DOI":"10.1016\/j.chroma.2019.460433"},{"key":"2862_CR23","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s12161-019-01477-9","volume":"12","author":"L Xu","year":"2019","unstructured":"Xu L, Burkin M, Eremin S, Dias ACP, Zhang X (2019) Development of competitive ELISA and CLEIA for quantitative analysis of polymyxin B. Food Anal Meth 12:1412\u20131419","journal-title":"Food Anal Methods"},{"key":"2862_CR24","doi-asserted-by":"crossref","unstructured":"Liu J, Huang Z, Ruan B, Wang H, Chen M, Rehman S, Wu P (2020)\u00a0Quantitative proteomic analysis reveals the mechanisms of polymyxin B toxicity to Escherichia coli. Chemosphere 259:127449","DOI":"10.1016\/j.chemosphere.2020.127449"},{"key":"2862_CR25","unstructured":"Pesez MB (1974)\u00a0Colorimetric and fluorimetric analysis of organic compounds and drugs. Marcel Dekker INC New York"},{"key":"2862_CR26","doi-asserted-by":"crossref","unstructured":"Atia NN, Marzouq MA, Hassan AI, Eltoukhi WE (2020)\u00a0A new spectrofluorimetric assay for quantification of Amisulpride and Memantine hydrochloride in real human plasma sample and pharmaceutical formulations via Hantzsch reaction, Spectrochim. Acta - Part A Mol Biomol Spectrosc 224:117388","DOI":"10.1016\/j.saa.2019.117388"},{"key":"2862_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.microc.2019.03.002","volume":"147","author":"MA Marzouq","year":"2019","unstructured":"Marzouq MA, Salman BI, Hussein SA, Ali MFB (2019) Hantzsch reaction approach for determination of teicoplanin and vancomycin in real human plasma: Application to pharmaceutical preparations and synthetic mixture with rifampicin for a drug-resistant strain of Staphylococcus aureus. Microchem J 147:25\u201329","journal-title":"Microchem J"},{"key":"2862_CR28","doi-asserted-by":"crossref","unstructured":"Abu-Hassan AA, Ali R, Derayea SM (2020)\u00a0A new convenient methodology based on dihydropyridine derivative for selective fluorimetric analysis of baclofen: Application to spiked urine and content uniformity evaluation. Spectrochim Acta - Part A Mol Biomol Spectrosc 248:119165","DOI":"10.1016\/j.saa.2020.119165"},{"key":"2862_CR29","first-page":"147","volume":"7","author":"MA El-Hamd","year":"2017","unstructured":"El-Hamd MA, Ali R, Haredy AM, Ahmed HM, Derayea SM, Abdelmageed OH (2017) Application of hantzsch reaction as a new method for spectrofluorimetric determination of some cephalosporins. J Appl Pharm Sci 7:147\u2013155","journal-title":"J Appl Pharm Sci"},{"key":"2862_CR30","doi-asserted-by":"crossref","unstructured":"Omar MA, Ahmed HM, Hammad MA, Derayea SM (2015)\u00a0Validated spectrofluorimetric method for determination of selected aminoglycosides. Spectrochim Acta - Part A Mol Biomol Spectrosc 135:472\u2013478","DOI":"10.1016\/j.saa.2014.07.020"},{"key":"2862_CR31","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/bio.3292","volume":"32","author":"MA Hammad","year":"2017","unstructured":"Hammad MA, Omar MA, Salman BI (2017) Utility of Hantzsch reaction for development of a highly sensitive spectrofluorimetric method for determination of alfuzosin and terazosin in bulk, dosage forms, and human plasma. Luminescence 32:1066\u20131071","journal-title":"Luminescence"},{"key":"2862_CR32","unstructured":"Guideline ICH (2005) Validation of analytical procedures: text and methodology Q2 (R1). In: International conference on harmonization. Geneva Switzerland"}],"container-title":["Journal of Fluorescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-021-02862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10895-021-02862-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-021-02862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:58:37Z","timestamp":1726448317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10895-021-02862-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2862"],"URL":"https:\/\/doi.org\/10.1007\/s10895-021-02862-6","relation":{},"ISSN":["1053-0509","1573-4994"],"issn-type":[{"value":"1053-0509","type":"print"},{"value":"1573-4994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"9 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Cosent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"No conflict of interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}